Microglial efferocytosis: Diving into the Alzheimer's disease gene pool.

TitleMicroglial efferocytosis: Diving into the Alzheimer's disease gene pool.
Publication TypeJournal Article
Year of Publication2022
AuthorsRomero-Molina C, Garretti F, Andrews SJ, Marcora E, Goate AM
JournalNeuron
Volume110
Issue21
Pagination3513-3533
Date Published11/2022
ISSN1097-4199
KeywordsAlzheimer Disease, Gene Pool, Genome-Wide Association Study, Humans, Microglia, Phagocytosis
Abstract

Genome-wide association studies and functional genomics studies have linked specific cell types, genes, and pathways to Alzheimer's disease (AD) risk. In particular, AD risk alleles primarily affect the abundance or structure, and thus the activity, of genes expressed in macrophages, strongly implicating microglia (the brain-resident macrophages) in the etiology of AD. These genes converge on pathways (endocytosis/phagocytosis, cholesterol metabolism, and immune response) with critical roles in core macrophage functions such as efferocytosis. Here, we review these pathways, highlighting relevant genes identified in the latest AD genetics and genomics studies, and describe how they may contribute to AD pathogenesis. Investigating the functional impact of AD-associated variants and genes in microglia is essential for elucidating disease risk mechanisms and developing effective therapeutic approaches.

DOI10.1016/j.neuron.2022.10.015
Alternate JournalNeuron
PubMed ID36327897
Grant ListP30 AG066514 / AG / NIA NIH HHS / United States
U01 AG032984 / AG / NIA NIH HHS / United States
U01 AG058635 / AG / NIA NIH HHS / United States